NCT04347031: A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19
- State
- Completed
- Phase
- Phase 2 and Phase 3
- People
- 320 taking part
- Started
- 8 Apr 2020
- Primary completion
- 1 Nov 2020
- Arms
- group 1 cohort 1
- Results
- None posted
- 8 Apr 2020: Trial started
- 15 Apr 2020: Trial registered
- 20 Nov 2020: Trial completed